Accounts Receivables - InterCure Ltd (NASDAQ:INCR) - Alpha Spread
I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.86 USD Market Closed
Market Cap: 84.8m USD
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InterCure Ltd
Accounts Receivables Peer Comparison

Comparables:
TEVA
RDHL
SLGL
MDWD
R
REKA

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
NASDAQ:INCR
Accounts Receivables
â‚Ş201.5m
CAGR 3-Years
132%
CAGR 5-Years
N/A
CAGR 10-Years
76%
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Accounts Receivables
$3.8B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-4%
Redhill Biopharma Ltd
NASDAQ:RDHL
Accounts Receivables
$974k
CAGR 3-Years
-68%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Sol Gel Technologies Ltd
NASDAQ:SLGL
Accounts Receivables
$6.1m
CAGR 3-Years
85%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Accounts Receivables
$2.9m
CAGR 3-Years
0%
CAGR 5-Years
39%
CAGR 10-Years
76%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Accounts Receivables
â‚Ş133.3m
CAGR 3-Years
15%
CAGR 5-Years
10%
CAGR 10-Years
2%

See Also

What is InterCure Ltd's Accounts Receivables?
Accounts Receivables
201.5m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Accounts Receivables amounts to 201.5m ILS.

What is InterCure Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
76%

Over the last year, the Accounts Receivables growth was 50%. The average annual Accounts Receivables growth rates for InterCure Ltd have been 132% over the past three years , and 76% over the past ten years .

Back to Top